The report was ok, but didn’t knock it out of the park. Was good for receivables and the liabilities have improved. Ultimately, many longs are frustrated that the revenues are down. Find the report, as it is posted by Billy. Take time to read and come up with your own dd. Try not to base an investing decision from what’s posted on message boards. I am mostly amused by arguments from both sides.
The only sound advice and statement I can offer you is to invest only what you can afford to lose and that POTN is generally not a day trade flip kind of stock. I’m no financial advisor, not a mod or am not compensated in any way shape or form here in this security. I offer literally just a mature opinion, and am not saying you should or should not invest. That would be irresponsible. But you asked about the report because you may be interested in the security.
Overall sentiment: It’s hard to decipher if the report was truly damaging or just a setback. Watch the price action literally over the next few days (seriously, to let the ticker weed out the report’s effect) even if it tanks or spikes, then chose a decent key support level to enter if you chose investment.
As for myself, I am long. I’ll either be settled as a bag holder and wait for the bottom to average up, or will remain patient.
IMHO some catalyst (slow summer/ FDA and weed sector positioning heading into 2020) are dragging all otc weed penny stocks.
I imagine I’ll be in for at least another year. Time and patience is key with POTN.
AI
